Three-month, randomized, parallel-group comparison of brimonidine–timolol versus dorzolamide–timolol fixed-combination therapy*

By Nixon Donald R.   Yan David B.   Chartrand Jean-Pierre   Piemontesi Roberto L.   Simonyi Susan   Hollander David A.  

Current Medical Research and Opinion, Vol. 25, Iss. 7, 2009-07 ,pp. : 1645-1653

Informa Healthcare

Access to resources Recommend Favorite

Intraocular pressure lowering effect of dorzolamide/timolol fixed combination in patients with glaucoma who were unresponsive to prostaglandin analogs/prostamides

By Martínez Antonio   Sánchez Manuel  

Current Medical Research and Opinion, Vol. 23, Iss. 3, 2007-03 ,pp. : 595-599

Informa Healthcare

Access to resources Recommend Favorite

Comparison of ocular hypotensive actions of fixed combinations of brimonidine/timolol and dorzolamide/timolol

By García-Feijoó Julián   Sáenz-Francés Federico   Martínez-de-la-Casa José María   Méndez-Hernández Carmen   Fernández-Vidal Ana   Calvo-González Cristina   García-Sánchez Julián  

Current Medical Research and Opinion, Vol. 26, Iss. 7, 2010-07 ,pp. : 1599-1606

Informa Healthcare

Access to resources Recommend Favorite

A comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucoma

By Martinez Antonio   Sanchez Manuel  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1025-1032

Informa Healthcare

Access to resources Recommend Favorite

24-hour control of intraocular pressure with 2% dorzolamide/0.5% timolol fixed-combination ophthalmic solution in open-angle glaucoma

By Feldman Robert M.   Stewart Robert H.   Stewart William C.   Jia Gang   Smugar Steven S.   Galet Vincent A.  

Current Medical Research and Opinion, Vol. 24, Iss. 8, 2008-08 ,pp. : 2403-2412

Informa Healthcare

Access to resources Recommend Favorite